Lumenis Be
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Lumenis Be sits in the top decile of US sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count).
Lumenis Be: 20 sponsored US clinical trials, 1 recruiting.
Lumenis Be sponsors 20 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 15 completed. The most-studied condition in this pipeline is Dry Eye Syndromes, with 1 trials.
Top-decile sponsor footprint
Lumenis Be ranks in the top decile of sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
15 of 18 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
20 total, page 1 of 1
Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser
NCT06885112
Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
NCT07405138
Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
NCT07039461
Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects with Dry Eye Disease
NCT05945069
Evaluation of Thermal Outcome and Safety of Nuera Tight RF System
NCT05957029
Safety and Efficacy Evaluation of SMART Camera Treatment Presets for Cutaneous Lesions Using IPL
NCT05755139
Feasibility of IPL Combined With RF for Treatment of DED Due to MGD
NCT05487547
Safety of Tinted Soft Scleral Eye Shields When IPL is Applied on Eyelids
NCT05168670
Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology
NCT04296201
Evaluation of the Safety and Efficacy of the NuEra Tight for Abdominal Circumference Reduction
NCT04406935
Effectiveness of Intense Pulsed Light for Improving Dry Eye Syndrome
NCT03396913
Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD
NCT02621593
Impact of the M22-IPL Acne Filter on Acne Vulgaris
NCT02180282
Impact of M22 Synergistic Sequential Treatment (SST)
NCT02032771
Impact of Synergistic Sequential Treatment (SST)
NCT01940445
Clinical Evaluation of LightSheer Duet 805nm HS Handpiece
NCT01801202
Scar Prevention Using Fractional Carbon Dioxide Laser Treatment
NCT01826942
Clinical Evaluation of M22 ResurFX 1565nm Module
NCT01796626
Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece
NCT01282866
Evaluation of the LightSheer HS Hand Piece as Compared to the LightSheer ET Hand Piece for the Intended Use of Hair Removal and Permanent Hair Reduction
NCT00657085
Therapeutic Areas
What is open in the Lumenis Be pipeline
1 recruiting of 20 indexed (5% open); 15 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Dry Eye Syndromes (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Lumenis Be: open-pipeline peers nationwide
Peers matched on 20 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
Lumenis Be sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 20 trials (± recruiting share)
- 59th Medical Wing · 20 trials · 15% recruiting
- Abiomed · 20 trials · 10% recruiting
- Agency for Healthcare Research and Quality (AHRQ) · 20 trials · 0% recruiting
- Alliance Foundation Trials · 20 trials · 15% recruiting
Sponsors near 5% open enrollment (± trial volume)
- Avera McKennan Hospital & University Health Center · 5% recruiting · 20 trials
- HonorHealth Research Institute · 5% recruiting · 20 trials
- Integra LifeSciences Corporation · 5% recruiting · 60 trials
- Nathan Kline Institute for Psychiatric Research · 5% recruiting · 20 trials
Related
What to do with this Lumenis Be page
20 registered trials is a research-attention snapshot, not an endorsement of Lumenis Be or any single study.
- 1 of Lumenis Be's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Dry Eye Syndromes is the condition Lumenis Be studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dry Eye Syndromes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Lumenis Be pipeline card: 20 registered trials from official public datasets.Report a data error.